Trials to watch: Phase III TB vaccines and MDR-TB treatments

resisttb
Apr 7
1 min read

After years without much advancement in new TB drug trials, a vaccine and two treatments are progressing through late-stage studies. As researchers predict the number of TB cases in the 16 major markets (US, France, Germany, Italy, Spain, UK, Japan, Australia, Brazil, Canada, China, India, Mexico, Russia, South Africa, and South Korea) to increase to 4.4 million in 2033, this article highlights a few current trials that could have major impacts on TB globally. Read more here.

Recent Posts

See All

New free eLearning Programme with The Union: 'Drug-Resistant Tuberculosis: From Clinical to Programmatic'

The International Union Against Tuberculosis and Lung Disease (The Union) is offering a free and accessible course created for clinicians and program managers who are working or planning to work with

Dr. Max O'Donnell Is Joining The RESIST-TB Steering Committee

RESIST-TB is excited to share that Dr. Max O'Donnell is joining our steering committee! Max is an Associate Professor of Medicine and Epidemiology at Columbia University Irving Medical Center, where h

UVA-Led Team Awarded Grant to Develop Global Resource Supporting Nurses Caring for Drug-Resistant Tuberculosis

Researchers from the University of Virginia have recently received a grant from the Pittsfield Anti-Tuberculosis Association to create a global, web-based resource to further support nurses that are c

Comments